English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse
  1. View item / 
  2. Item Summary

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Carcinoembryonales Antigen (CEA): Klinische Wertung der Rezidivierungs- und Metastasierungsprognosen mittels CEA-Verlaufsanalyse bei Patienten mit Adenokarzinomen des GastrointestinaltraktesCarcinoembryonic antigen (CEA)

MPS-Authors
/persons/resource/persons285242

Staab,  HJ
Anderer Group, Friedrich Miescher Laboratory, Max Planck Society;

/persons/resource/persons282624

Anderer,  FA
Anderer Group, Friedrich Miescher Laboratory, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Staab, H., Anderer, F., Stumpf, E., & Fischer, R. (1977). Carcinoembryonales Antigen (CEA): Klinische Wertung der Rezidivierungs- und Metastasierungsprognosen mittels CEA-Verlaufsanalyse bei Patienten mit Adenokarzinomen des GastrointestinaltraktesCarcinoembryonic antigen (CEA). Deutsche Medizinische Wochenschrift, 102(30), 1082-1086. doi:10.1055/s-0028-1105468.


Cite as: https://hdl.handle.net/21.11116/0000-000F-507E-A
Abstract
Serial determinations of CEA concentrations in serum were performed postoperatively in 303 patients with histologically confirmed adenocarcinoma of the gastrointestinal tract. The trend of the time course of computerised CEA curves made early diagnosis of recurrence or metastases possible. Diagnosis of recurrence by means of a rise in CEA concentration preceded positive clinical diagnosis by up to 10 months. In all 26 cases confirmation was obtained by second-look operation or other diagnostic means. Analysis of serial CEA measurements made it possible to distinguish between generalised metastasization and local recurrence of the tumour, on the one hand, and limited metastasization at the site of recurrence, on the other.